Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - ELEC LB - 1. AU - Public Health England J2 - Chronic Kidney Disease Prevalence Model PY - 2014 ER - TY - ELEC LB - 2. AU - United Kingdom Renal Registry J2 - 24th Annual Report PY - 2022 ER - TY - JOUR LB - 3. AU - Kerr, M AU - Bray, B AU - Medcalf, J AU - O’Donoghue, DJ AU - Matthews, B TI - Estimating the financial cost of chronic kidney disease to the NHS in England J2 - Nephrol Dial Transplant SP - iii73 PY - 2012 VL - 27 SP - iii73 ER - TY - JOUR LB - 4. AU - Kent, S AU - Schlackow, I AU - Lozano-Kuhne, J AU - Reith, C AU - Emberson, J AU - Haynes, R AU - SHARP Collaborative Group TI - What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? J2 - BMC Nephrol SP - 65 PY - 2015 VL - 16 SP - 65 ER - TY - JOUR LB - 5. AU - van der Velde, M AU - Matsushita, K AU - Coresh, J AU - Astor, BC AU - Woodward, M AU - Levey, A AU - Chronic Kidney Disease Prognosis Consortium TI - Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts J2 - Kidney Int SP - 1341 PY - 2011 VL - 79 SP - 1341 ER - TY - JOUR LB - 6. AU - Gansevoort, RT AU - Matsushita, K AU - van der Velde, M AU - Astor, BC AU - Woodward, M AU - Levey, AS AU - Chronic Kidney Disease Prognosis Consortium TI - Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts J2 - Kidney Int SP - 93 PY - 2011 VL - 80 SP - 93 ER - TY - JOUR LB - 7. AU - Matsushita, K AU - van der Velde, M AU - Astor, BC AU - Woodward, M AU - Levey, AS AU - de Jong, PE AU - Chronic Kidney Disease Prognosis Consortium TI - Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis J2 - Lancet SP - 2073 PY - 2010 VL - 375 SP - 2073 ER - TY - JOUR LB - 8. AU - Grams, ME AU - Sang, Y AU - Ballew, SH AU - Gansevoort, RT AU - Kimm, H AU - Kovesdy, CP AU - CKD Prognosis Consortium TI - A meta-analysis of the association of estimated GFR, albuminuria, age, race, and sex with acute kidney injury J2 - Am J Kidney Dis SP - 591 PY - 2015 VL - 66 SP - 591 ER - TY - JOUR LB - 9. AU - Hannan, M AU - Ansari, S AU - Meza, N AU - Anderson, AH AU - Srivastava, A AU - Waikar, S AU - CRIC Study Investigators TI - Risk factors for CKD progression: overview of findings from the CRIC study J2 - Clin J Am Soc Nephrol SP - 648 PY - 2021 VL - 16 SP - 648 ER - TY - JOUR LB - 10. AU - Brenner, BM AU - Cooper, ME AU - de Zeeuw, D AU - Keane, WF AU - Mitch, WE AU - Parving, HH AU - RENAAL Study Investigators TI - Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy J2 - N Engl J Med SP - 861 PY - 2001 VL - 345 SP - 861 ER - TY - JOUR LB - 11. AU - Lewis, EJ AU - Hunsicker, LG AU - Bain, RP AU - Rohde, RD TI - The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group J2 - N Engl J Med SP - 1456 PY - 1993 VL - 329 SP - 1456 ER - TY - JOUR LB - 12. AU - Heart Outcomes Prevention Evaluation (HOPE) Study Investigators TI - Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy J2 - Lancet SP - 253 PY - 2000 VL - 355 SP - 253 ER - TY - JOUR LB - 13. AU - Gruppo Italiano di Studi Epidemiologici in Nefrologia TI - Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy J2 - Lancet SP - 1857 PY - 1997 VL - 349 SP - 1857 ER - TY - JOUR LB - 14. AU - Ruggenenti, P AU - Pagano, E AU - Tammuzzo, L AU - Benini, R AU - Garattini, L AU - Remuzzi, G TI - Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies J2 - Kidney Int SP - 286 PY - 2001 VL - 59 SP - 286 ER - TY - JOUR LB - 15. AU - Heerspink, HJL AU - Stefansson, BV AU - Correa-Rotter, R AU - Chertow, GM AU - Greene, T AU - Hou, FF AU - DAPA-CKD Trial Committees and Investigators TI - Dapagliflozin in patients with chronic kidney disease J2 - N Engl J Med SP - 1436 PY - 2020 VL - 383 SP - 1436 ER - TY - JOUR LB - 16. AU - Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium TI - Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials J2 - Lancet SP - 1788 PY - 2022 VL - 400 SP - 1788 ER - TY - JOUR LB - 17. AU - Staplin, N AU - Roddick, AJ AU - Emberson, J AU - Reith, C AU - Riding, A AU - Wonnacott, A TI - Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials J2 - EClinicalMedicine SP - 101163 PY - 2021 VL - 41 SP - 101163 ER - TY - JOUR LB - 18. AU - Herrington, WG AU - Staplin, N AU - Wanner, C AU - Green, JB AU - Hauske, SJ AU - Emberson, JR AU - The EMPA-KIDNEY Collaborative Group TI - Empagliflozin in patients with chronic kidney disease J2 - N Engl J Med SP - 117 PY - 2023 VL - 388 SP - 117 ER - TY - JOUR LB - 19. AU - Perkovic, V AU - Jardine, MJ AU - Neal, B AU - Bompoint, S AU - Heerspink, HJL AU - Charytan, DM AU - CREDENCE Trial Investigators TI - Canagliflozin and renal outcomes in type 2 diabetes and nephropathy J2 - N Engl J Med SP - 2295 PY - 2019 VL - 380 SP - 2295 ER - TY - JOUR LB - 20. AU - Vart, P AU - Vaduganathan, M AU - Jongs, N AU - Remuzzi, G AU - Wheeler, DC AU - Hou, FF TI - Estimated lifetime benefit of combined RAAS and SGLT2 inhibitor therapy in patients with albuminuric CKD without diabetes J2 - Clin J Am Soc Nephrol SP - 1754 PY - 2022 VL - 17 SP - 1754 ER - TY - JOUR LB - 21. AU - Gaspari, F AU - Perico, N AU - Ruggenenti, P AU - Mosconi, L AU - Amuchastegui, CS AU - Guerini, E TI - Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate J2 - J Am Soc Nephrol SP - 257 PY - 1995 VL - 6 SP - 257 ER - TY - GEN LB - 22. AU - National Institute for Health and Care Excellence J2 - Chronic Kidney Disease. Early Identification and Management of Chronic Kidney Disease in Adults in Primary and Secondary Care PY - 2014 ER - TY - JOUR LB - 23. AU - Stevens, PE AU - O’Donoghue, DJ AU - de Lusignan, S AU - Van Vlymen, J AU - Klebe, B AU - Middleton, R TI - Chronic kidney disease management in the United Kingdom: NEOERICA project results J2 - Kidney Int SP - 92 PY - 2007 VL - 72 SP - 92 ER - TY - JOUR LB - 24. AU - de Lusignan, S AU - Tomson, C AU - Harris, K AU - van Vlymen, J AU - Gallagher, H TI - Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease J2 - Nephron Clin Pract SP - c213 PY - 2011 VL - 117 SP - c213 ER - TY - JOUR LB - 25. AU - Moynihan, R AU - Doust, J AU - Henry, D TI - Preventing overdiagnosis: how to stop harming the healthy J2 - BMJ SP - e3502 PY - 2012 VL - 344 SP - e3502 ER - TY - JOUR LB - 26. AU - Kyhse-Andersen, J AU - Schmidt, C AU - Nordin, G AU - Andersson, B AU - Nilsson-Ehle, P AU - Lindstrom, V AU - Grubb, A TI - Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate J2 - Clin Chem SP - 1921 PY - 1994 VL - 40 SP - 1921 ER - TY - JOUR LB - 27. AU - Kidney Disease Improving Global Outcomes TI - Clinical practice guideline for the evaluation and management of chronic kidney disease J2 - Kidney Int SP - 1 PY - 2013 VL - 3 SP - 1 ER - TY - JOUR LB - 28. AU - Inker, LA AU - Schmid, CH AU - Tighiouart, H AU - Eckfeldt, JH AU - Feldman, HI AU - Greene, T AU - CKD-EPI Investigators TI - Estimating glomerular filtration rate from serum creatinine and cystatin C J2 - N Engl J Med SP - 20 PY - 2012 VL - 367 SP - 20 ER - TY - JOUR LB - 29. AU - Peralta, CA AU - Katz, R AU - Sarnak, MJ AU - Ix, J AU - Fried, LF AU - De Boer, I TI - Cystatin C identifies chronic kidney disease patients at higher risk for complications J2 - J Am Soc Nephrol SP - 147 PY - 2011 VL - 22 SP - 147 ER - TY - JOUR LB - 30. AU - Lees, JS AU - Welsh, CE AU - Celis-Morales, CA AU - Mackay, D AU - Lewsey, J AU - Gray, SR TI - Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease J2 - Nat Med SP - 1753 PY - 2019 VL - 25 SP - 1753 ER - TY - JOUR LB - 31. AU - Levey, AS AU - Bosch, JP AU - Lewis, JB AU - Greene, T AU - Rogers, N AU - Roth, D TI - A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group J2 - Ann Intern Med SP - 461 PY - 1999 VL - 130 SP - 461 ER - TY - JOUR LB - 32. AU - Levey, AS AU - Stevens, LA AU - Schmid, CH AU - Zhang, YL AU - Castro, AF AU - Feldman, HI AU - CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) TI - A new equation to estimate glomerular filtration rate J2 - Ann Intern Med SP - 604 PY - 2009 VL - 150 SP - 604 ER - TY - JOUR LB - 33. AU - Hsu, CY AU - Bansal, N TI - Measured GFR as ‘gold standard’ – all that glitters is not gold? J2 - Clin J Am Soc Nephrol SP - 1813 PY - 2011 VL - 6 SP - 1813 ER - TY - JOUR LB - 34. AU - Kwong, YTD AU - Stevens, LA AU - Selvin, E AU - Zhang, YL AU - Greene, T AU - Van Lente, F TI - Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations J2 - Am J Kidney Dis SP - 39 PY - 2010 VL - 56 SP - 39 ER - TY - JOUR LB - 35. AU - Fraser, CG AU - Harris, EK TI - Generation and application of data on biological variation in clinical chemistry J2 - Crit Rev Clin Lab Sci SP - 409 PY - 1989 VL - 27 SP - 409 ER - TY - JOUR LB - 36. AU - Bartlett, WA AU - Braga, F AU - Carobene, A AU - Coskun, A AU - Prusa, R AU - Fernandez-Calle, P AU - Biological Variation Working Group, European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) TI - A checklist for critical appraisal of studies of biological variation J2 - Clin Chem Lab Med SP - 879 PY - 2015 VL - 53 SP - 879 ER - TY - JOUR LB - 37. AU - Levey, AS AU - Greene, T AU - Kusek, JW AU - Beck, GJ TI - A simplified equation to predict glomerular filtration rate from serum creatinine J2 - J Am Soc Nephrol SP - 155A PY - 2000 VL - 11 SP - 155A ER - TY - JOUR LB - 38. AU - Levey, AS AU - Coresh, J AU - Greene, T AU - Stevens, LA AU - Zhang, YL AU - Hendriksen, S AU - Chronic Kidney Disease Epidemiology Collaboration TI - Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate J2 - Ann Intern Med SP - 247 PY - 2006 VL - 145 SP - 247 ER - TY - JOUR LB - 39. AU - Myers, GL AU - Miller, WG AU - Coresh, J AU - Fleming, J AU - Greenberg, N AU - Greene, T AU - National Kidney Disease Education Program Laboratory Working Group TI - Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program J2 - Clin Chem SP - 5 PY - 2006 VL - 52 SP - 5 ER - TY - GEN LB - 40. AU - National Institute for Health and Care Excellence J2 - Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care. Clinical Guideline 73 PY - 2008 ER - TY - JOUR LB - 41. AU - Earley, A AU - Miskulin, D AU - Lamb, EJ AU - Levey, AS AU - Uhlig, K TI - Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review J2 - Ann Intern Med SP - 785 PY - 2012 VL - 156 SP - 785 ER - TY - JOUR LB - 42. AU - Schaeffner, ES AU - Ebert, N AU - Delanaye, P AU - Frei, U AU - Gaedeke, J AU - Jakob, O TI - Two novel equations to estimate kidney function in persons aged 70 years or older J2 - Ann Intern Med SP - 471 PY - 2012 VL - 157 SP - 471 ER - TY - JOUR LB - 43. AU - Grubb, A AU - Horio, M AU - Hansson, LO AU - Björk, J AU - Nyman, U AU - Flodin, M TI - Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator J2 - Clin Chem SP - 974 PY - 2014 VL - 60 SP - 974 ER - TY - JOUR LB - 44. AU - Pottel, H AU - Hoste, L AU - Dubourg, L AU - Ebert, N AU - Schaeffner, E AU - Eriksen, BO TI - An estimated glomerular filtration rate equation for the full age spectrum J2 - Nephrol Dial Transplant SP - 798 PY - 2016 VL - 31 SP - 798 ER - TY - JOUR LB - 45. AU - Pottel, H AU - Delanaye, P AU - Schaeffner, E AU - Dubourg, L AU - Eriksen, BO AU - Melsom, T TI - Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C J2 - Nephrol Dial Transplant SP - 497 PY - 2017 VL - 32 SP - 497 ER - TY - JOUR LB - 46. AU - Björk, J AU - Bäck, SE AU - Ebert, N AU - Evans, M AU - Grubb, A AU - Hansson, M TI - GFR estimation based on standardized creatinine and cystatin C: a European multicenter analysis in older adults J2 - Clin Chem Lab Med SP - 422 PY - 2018 VL - 56 SP - 422 ER - TY - JOUR LB - 47. AU - Pottel, H AU - Björk, J AU - Courbebaisse, M AU - Couzi, L AU - Ebert, N AU - Eriksen, BO TI - Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate: a cross-sectional analysis of pooled data J2 - Ann Intern Med SP - 183 PY - 2021 VL - 174 SP - 183 ER - TY - JOUR LB - 48. AU - Inker, LA AU - Eneanya, ND AU - Coresh, J AU - Tighiouart, H AU - Wang, D AU - Sang, Y AU - Chronic Kidney Disease Epidemiology Collaboration TI - New creatinine- and cystatin C-based equations to estimate GFR without race J2 - N Engl J Med SP - 1737 PY - 2021 VL - 385 SP - 1737 ER - TY - JOUR LB - 49. AU - Dharnidharka, VR AU - Kwon, C AU - Stevens, G TI - Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis J2 - Am J Kidney Dis SP - 221 PY - 2002 VL - 40 SP - 221 ER - TY - JOUR LB - 50. AU - Laterza, OF AU - Price, CP AU - Scott, MG TI - Cystatin C: an improved estimator of glomerular filtration rate? J2 - Clin Chem SP - 699 PY - 2002 VL - 48 SP - 699 ER - TY - JOUR LB - 51. AU - Grubb, A AU - Blirup-Jensen, S AU - Lindström, V AU - Schmidt, C AU - Althaus, H AU - Zegers, I AU - IFCC Working Group on Standardisation of Cystatin C (WG-SCC) TI - First certified reference material for cystatin C in human serum ERM-DA471/IFCC J2 - Clin Chem Lab Med SP - 1619 PY - 2010 VL - 48 SP - 1619 ER - TY - JOUR LB - 52. AU - Kilbride, HS AU - Stevens, PE AU - Eaglestone, G AU - Knight, S AU - Carter, JL AU - Delaney, MP TI - Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly J2 - Am J Kidney Dis SP - 57 PY - 2013 VL - 61 SP - 57 ER - TY - JOUR LB - 53. AU - Björk, J AU - Grubb, A AU - Sterner, G AU - Nyman, U TI - Revised equations for estimating glomerular filtration rate based on the Lund-Malmö Study cohort J2 - Scand J Clin Lab Invest SP - 232 PY - 2011 VL - 71 SP - 232 ER - TY - JOUR LB - 54. AU - Hounkpatin, HO AU - Fraser, SDS AU - Honney, R AU - Dreyer, G AU - Brettle, A AU - Roderick, PJ TI - Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review J2 - BMC Nephrol SP - 217 PY - 2020 VL - 21 SP - 217 ER - TY - JOUR LB - 55. AU - Pallayova, M AU - Rayner, H AU - Taheri, S AU - Dasgupta, I TI - Is there a difference in progression of renal disease between South Asian and white European diabetic adults with moderately reduced kidney function? J2 - J Diabetes Complications SP - 761 PY - 2015 VL - 29 SP - 761 ER - TY - JOUR LB - 56. AU - Gerber, C AU - Cai, X AU - Lee, J AU - Craven, T AU - Scialla, J AU - Souma, N TI - Incidence and progression of chronic kidney disease in black and white individuals with type 2 diabetes J2 - Clin J Am Soc Nephrol SP - 884 PY - 2018 VL - 13 SP - 884 ER - TY - JOUR LB - 57. AU - Mathur, R AU - Dreyer, G AU - Yaqoob, MM AU - Hull, SA TI - Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study J2 - BMJ Open SP - e020145 PY - 2018 VL - 8 SP - e020145 ER - TY - JOUR LB - 58. AU - Major, RW AU - Shepherd, D AU - Medcalf, JF AU - Xu, G AU - Gray, LJ AU - Brunskill, NJ TI - Comorbidities and outcomes in South Asian individuals with chronic kidney disease: an observational primary care cohort J2 - Nephrol Dial Transplant SP - 108 PY - 2021 VL - 37 SP - 108 ER - TY - ELEC LB - 59. AU - National Institute for Health and Care Excellence J2 - Chronic Kidney Disease: Assessment and Management [NG203] PY - 2021 ER - TY - JOUR LB - 60. AU - Lewis, J AU - Agodoa, L AU - Cheek, D AU - Greene, T AU - Middleton, J AU - O’Connor, D AU - African-American Study of Hypertension and Kidney Disease TI - Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate J2 - Am J Kidney Dis SP - 744 PY - 2001 VL - 38 SP - 744 ER - TY - JOUR LB - 61. AU - Ma, YC AU - Zuo, L AU - Chen, JH AU - Luo, Q AU - Yu, XQ AU - Li, Y TI - Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease J2 - J Am Soc Nephrol SP - 2937 PY - 2006 VL - 17 SP - 2937 ER - TY - JOUR LB - 62. AU - Matsuo, S AU - Imai, E AU - Horio, M AU - Yasuda, Y AU - Tomita, K AU - Nitta, K AU - Collaborators developing the Japanese equation for estimated GFR TI - Revised equations for estimated GFR from serum creatinine in Japan J2 - Am J Kidney Dis SP - 982 PY - 2009 VL - 53 SP - 982 ER - TY - JOUR LB - 63. AU - Horio, M AU - Imai, E AU - Yasuda, Y AU - Watanabe, T AU - Matsuo, S TI - Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates J2 - Am J Kidney Dis SP - 32 PY - 2010 VL - 56 SP - 32 ER - TY - JOUR LB - 64. AU - Teo, BW AU - Xu, H AU - Wang, D AU - Li, J AU - Sinha, AK AU - Shuter, B TI - GFR estimating equations in a multiethnic Asian population J2 - Am J Kidney Dis SP - 56 PY - 2011 VL - 58 SP - 56 ER - TY - JOUR LB - 65. AU - Praditpornsilpa, K AU - Townamchai, N AU - Chaiwatanarat, T AU - Tiranathanagul, K AU - Katawatin, P AU - Susantitaphong, P TI - The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations J2 - Nephrol Dial Transplant SP - 2780 PY - 2011 VL - 26 SP - 2780 ER - TY - JOUR LB - 66. AU - Wang, Y AU - Levey, AS AU - Inker, LA AU - Jessani, S AU - Bux, R AU - Samad, Z TI - Performance and determinants of serum creatinine and cystatin C-based GFR estimating equations in South Asians J2 - Kidney Int Rep SP - 962 PY - 2021 VL - 6 SP - 962 ER - TY - JOUR LB - 67. AU - Delgado, C AU - Baweja, M AU - Crews, DC AU - Eneanya, ND AU - Gadegbeku, CA AU - Inker, LA TI - A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease J2 - Am J Kidney Dis SP - 268 PY - 2022 VL - 79 SP - 268 ER - TY - JOUR LB - 68. AU - Keith, DS AU - Nichols, GA AU - Gullion, CM AU - Brown, JB AU - Smith, DH TI - Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization J2 - Arch Intern Med SP - 659 PY - 2004 VL - 164 SP - 659 ER - TY - JOUR LB - 69. AU - Hemmelgarn, BR AU - Zhang, J AU - Manns, BJ AU - Tonelli, M AU - Larsen, E AU - Ghali, WA TI - Progression of kidney dysfunction in the community-dwelling elderly J2 - Kidney Int SP - 2155 PY - 2006 VL - 69 SP - 2155 ER - TY - JOUR LB - 70. AU - Ruggenenti, P AU - Perna, A AU - Remuzzi, G TI - ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy J2 - J Am Soc Nephrol SP - 2832 PY - 2001 VL - 12 SP - 2832 ER - TY - JOUR LB - 71. AU - Gall, MA AU - Nielsen, FS AU - Smidt, UM AU - Parving, HH TI - The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy J2 - Diabetologia SP - 1071 PY - 1993 VL - 36 SP - 1071 ER - TY - JOUR LB - 72. AU - MacIsaac, RJ AU - Tsalamandris, C AU - Panagiotopoulos, S AU - Smith, TJ AU - McNeil, KJ AU - Jerums, G TI - Nonalbuminuric renal insufficiency in type 2 diabetes J2 - Diabetes Care SP - 195 PY - 2004 VL - 27 SP - 195 ER - TY - JOUR LB - 73. AU - Parving, HH AU - Andersen, AR AU - Smidt, UM AU - Hommel, E AU - Mathiesen, ER AU - Svendsen, PA TI - Effect of antihypertensive treatment on kidney function in diabetic nephropathy J2 - Br Med J (Clin Res Ed) SP - 1443 PY - 1987 VL - 294 SP - 1443 ER - TY - JOUR LB - 74. AU - Björck, S AU - Nyberg, G AU - Mulec, H AU - Granerus, G AU - Herlitz, H AU - Aurell, M TI - Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy J2 - Br Med J (Clin Res Ed) SP - 471 PY - 1986 VL - 293 SP - 471 ER - TY - JOUR LB - 75. AU - Hoefield, RA AU - Kalra, PA AU - Baker, PG AU - Sousa, I AU - Diggle, PJ AU - Gibson, MJ TI - The use of eGFR and ACR to predict decline in renal function in people with diabetes J2 - Nephrol Dial Transplant SP - 887 PY - 2011 VL - 26 SP - 887 ER - TY - JOUR LB - 76. AU - Gowans, EM AU - Fraser, CG TI - Biological variation of serum and urine creatinine and creatinine clearance: ramifications for interpretation of results and patient care J2 - Ann Clin Biochem SP - 259 PY - 1988 VL - 25 SP - 259 ER - TY - JOUR LB - 77. AU - Keevil, BG AU - Kilpatrick, ES AU - Nichols, SP AU - Maylor, PW TI - Biological variation of cystatin C: implications for the assessment of glomerular filtration rate J2 - Clin Chem SP - 1535 PY - 1998 VL - 44 SP - 1535 ER - TY - JOUR LB - 78. AU - Reinhard, M AU - Erlandsen, EJ AU - Randers, E TI - Biological variation of cystatin C and creatinine J2 - Scand J Clin Lab Invest SP - 831 PY - 2009 VL - 69 SP - 831 ER - TY - JOUR LB - 79. AU - Delanaye, P AU - Cavalier, E AU - Depas, G AU - Chapelle, JP AU - Krzesinski, JM TI - New data on the intraindividual variation of cystatin C J2 - Nephron Clin Pract SP - c246 PY - 2008 VL - 108 SP - c246 ER - TY - JOUR LB - 80. AU - Andersen, TB AU - Erlandsen, EJ AU - Frøkiaer, J AU - Eskild-Jensen, A AU - Brøchner-Mortensen, J TI - Comparison of within- and between-subject variation of serum cystatin C and serum creatinine in children aged 2–13 years J2 - Scand J Clin Lab Invest SP - 54 PY - 2010 VL - 70 SP - 54 ER - TY - JOUR LB - 81. AU - Bandaranayake, N AU - Ankrah-Tetteh, T AU - Wijeratne, S AU - Swaminathan, R TI - Intra-individual variation in creatinine and cystatin C J2 - Clin Chem Lab Med SP - 1237 PY - 2007 VL - 45 SP - 1237 ER - TY - JOUR LB - 82. AU - Toffaletti, JG AU - McDonnell, EH TI - Variation of serum creatinine, cystatin C, and creatinine clearance tests in persons with normal renal function J2 - Clin Chim Acta SP - 115 PY - 2008 VL - 395 SP - 115 ER - TY - JOUR LB - 83. AU - Ruggenenti, P AU - Gaspari, F AU - Cannata, A AU - Carrara, F AU - Cella, C AU - Ferrari, S AU - GFR-ADPKD Study Group TI - Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study J2 - PLOS ONE SP - e32533 PY - 2012 VL - 7 SP - e32533 ER - TY - JOUR LB - 84. AU - Padala, S AU - Tighiouart, H AU - Inker, LA AU - Contreras, G AU - Beck, GJ AU - Lewis, J TI - Accuracy of a GFR estimating equation over time in people with a wide range of kidney function J2 - Am J Kidney Dis SP - 217 PY - 2012 VL - 60 SP - 217 ER - TY - JOUR LB - 85. AU - Peralta, CA AU - Shlipak, MG AU - Judd, S AU - Cushman, M AU - McClellan, W AU - Zakai, NA TI - Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality J2 - JAMA SP - 1545 PY - 2011 VL - 305 SP - 1545 ER - TY - JOUR LB - 86. AU - Hounkpatin, HO AU - Harris, S AU - Fraser, SDS AU - Day, J AU - Mindell, JS AU - Taal, MW TI - Prevalence of chronic kidney disease in adults in England: comparison of nationally representative cross-sectional surveys from 2003 to 2016 J2 - BMJ Open SP - e038423 PY - 2020 VL - 10 SP - e038423 ER - TY - JOUR LB - 87. AU - Levin, A AU - Stevens, PE TI - Early detection of CKD: the benefits, limitations and effects on prognosis J2 - Nat Rev Nephrol SP - 446 PY - 2011 VL - 7 SP - 446 ER - TY - JOUR LB - 88. AU - Lamb, EJ AU - Brettell, EA AU - Cockwell, P AU - Dalton, N AU - Deeks, JJ AU - Harris, K AU - eGFR-C study group TI - The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease – prospective longitudinal study in a multiethnic population J2 - BMC Nephrol SP - 13 PY - 2014 VL - 15 SP - 13 ER - TY - JOUR LB - 89. AU - Erley, CM AU - Bader, BD AU - Berger, ED AU - Vochazer, A AU - Jorzik, JJ AU - Dietz, K AU - Risler, T TI - Plasma clearance of iodine contrast media as a measure of glomerular filtration rate in critically ill patients J2 - Crit Care Med SP - 1544 PY - 2001 VL - 29 SP - 1544 ER - TY - JOUR LB - 90. AU - Schwartz, GJ AU - Work, DF TI - Measurement and estimation of GFR in children and adolescents J2 - Clin J Am Soc Nephrol SP - 1832 PY - 2009 VL - 4 SP - 1832 ER - TY - JOUR LB - 91. AU - Gaspari, F AU - Perico, N AU - Matalone, M AU - Signorini, O AU - Azzollini, N AU - Mister, M AU - Remuzzi, G TI - Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease J2 - J Am Soc Nephrol SP - 310 PY - 1998 VL - 9 SP - 310 ER - TY - JOUR LB - 92. AU - Haycock, GB AU - Schwartz, GJ AU - Wisotsky, DH TI - Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults J2 - J Pediatr SP - 62 PY - 1978 VL - 93 SP - 62 ER - TY - JOUR LB - 93. AU - Du Bois, D AU - Du Bois, EF TI - A formula to estimate the approximate surface area if height and weight be known J2 - Arch Intern Med SP - 863 PY - 1916 VL - 17 SP - 863 ER - TY - JOUR LB - 94. AU - Shardlow, A AU - McIntyre, NJ AU - Fluck, RJ AU - McIntyre, CW AU - Taal, MW TI - Chronic kidney disease in primary care: outcomes after five years in a prospective cohort study J2 - PLOS Med SP - e1002128 PY - 2016 VL - 13 SP - e1002128 ER - TY - JOUR LB - 95. AU - Turin, TC AU - Tonelli, M AU - Manns, BJ AU - Ravani, P AU - Ahmed, SB AU - Hemmelgarn, BR TI - Chronic kidney disease and life expectancy J2 - Nephrol Dial Transplant SP - 3182 PY - 2012 VL - 27 SP - 3182 ER - TY - JOUR LB - 96. AU - Bellomo, R AU - Ronco, C AU - Kellum, JA AU - Mehta, RL AU - Palevsky, P AU - Acute Dialysis Quality Initiative workgroup TI - Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group J2 - Crit Care SP - R204 PY - 2004 VL - 8 SP - R204 ER - TY - JOUR LB - 97. AU - Rowe, C AU - Sitch, AJ AU - Barratt, J AU - Brettell, EA AU - Cockwell, P AU - Dalton, RN AU - eGFR-C Study Group TI - Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease J2 - Kidney Int SP - 429 PY - 2019 VL - 96 SP - 429 ER - TY - JOUR LB - 98. AU - Bröchner-Mortensen, J TI - A simple method for the determination of glomerular filtration rate J2 - Scand J Clin Lab Invest SP - 271 PY - 1972 VL - 30 SP - 271 ER - TY - JOUR LB - 99. AU - Blake, GM AU - Roe, D AU - Lazarus, CR TI - Long-term precision of glomerular filtration rate measurements using 51Cr-EDTA plasma clearance J2 - Nucl Med Commun SP - 776 PY - 1997 VL - 18 SP - 776 ER - TY - BOOK LB - 100. AU - Burniston, M J2 - Clinical Guideline for the Measurement of Glomerular Filtration Rate (GFR) Using Plasma Sampling PY - 2018 ER - TY - JOUR LB - 101. AU - Bargnoux, AS AU - Pieroni, L AU - Cristol, JP AU - Kuster, N AU - Delanaye, P AU - Carlier, MC AU - Société Française de Biologie Clinique (SFBC) TI - Multicenter evaluation of cystatin C measurement after assay standardization J2 - Clin Chem SP - 833 PY - 2017 VL - 63 SP - 833 ER - TY - JOUR LB - 102. AU - National Kidney Foundation TI - K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification J2 - Am J Kidney Dis SP - S1 PY - 2002 VL - 39 SP - S1 ER - TY - BOOK LB - 103. AU - Cohen, J J2 - Statistical Power Analysis for the Behavioural Sciences PY - 1988 ER - TY - ELEC LB - 104. AU - National Institute for Health and Care Excellence J2 - Obesity: Identification, Assessment and Management (CG189) PY - 2014 ER - TY - JOUR LB - 105. AU - O’Brien, TE AU - Funk, GM TI - A gentle introduction to optimal design for regression models J2 - Am Stat SP - 265 PY - 2003 VL - 57 SP - 265 ER - TY - JOUR LB - 106. AU - Simundic, AM AU - Kackov, S AU - Miler, M AU - Fraser, CG AU - Petersen, PH TI - Terms and symbols used in studies on biological variation: the need for harmonization J2 - Clin Chem SP - 438 PY - 2015 VL - 61 SP - 438 ER - TY - JOUR LB - 107. AU - Cole, TJ TI - Sympercents: symmetric percentage differences on the 100 log(e) scale simplify the presentation of log transformed data J2 - Stat Med SP - 3109 PY - 2000 VL - 19 SP - 3109 ER - TY - JOUR LB - 108. AU - Koopmans, LH AU - Owen, DB AU - Rosenblatt, JI TI - Confidence intervals for the coefficient of variation for the normal and log normal distributions J2 - Biometrika SP - 25 PY - 1964 VL - 51 SP - 25 ER - TY - BOOK LB - 109. AU - Burdick, RK AU - Graybill, FA J2 - Confidence Intervals on Variance Components PY - 1992 ER - TY - JOUR LB - 110. AU - Fokkema, MR AU - Herrmann, Z AU - Muskiet, FA AU - Moecks, J TI - Reference change values for brain natriuretic peptides revisited J2 - Clin Chem SP - 1602 PY - 2006 VL - 52 SP - 1602 ER - TY - JOUR LB - 111. AU - Schulz, KF AU - Altman, DG AU - Moher, D AU - CONSORT Group TI - CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials J2 - PLOS Med SP - e1000251 PY - 2010 VL - 7 SP - e1000251 ER - TY - JOUR LB - 112. AU - Sutton, AJ AU - Breheny, K AU - Deeks, J AU - Khunti, K AU - Sharpe, C AU - Ottridge, RS AU - eGFR-C study group TI - Methods used in economic evaluations of chronic kidney disease testing – a systematic review J2 - PLOS ONE SP - e0140063 PY - 2015 VL - 10 SP - e0140063 ER - TY - BOOK LB - 113. AU - Perera, R AU - Stevens, R AU - Aronson, JK AU - Banerjee, A AU - Evans, J AU - Feakins, BG J2 - Long-term Monitoring in Primary Care for Chronic Kidney Disease and Chronic Heart Failure: A Multi-Method Research Programme PY - 2021 ER - TY - ELEC LB - 114. AU - National Institute for Health and Care Excellence J2 - Cardiovascular Disease: Risk Assessment and Reduction, Including Lipid Modification. Clinical Guideline [CG181] PY - 2014 ER - TY - JOUR LB - 115. AU - Smith, AF AU - Shinkins, B AU - Hall, PS AU - Hulme, CT AU - Messenger, MP TI - Toward a framework for outcome-based analytical performance specifications: a methodology review of indirect methods for evaluating the impact of measurement uncertainty on clinical outcomes J2 - Clin Chem SP - 1363 PY - 2019 VL - 65 SP - 1363 ER - TY - ELEC LB - 116. AU - NHS J2 - National Cost Collection 2019/20 Report PY - 2020 ER - TY - BOOK LB - 117. AU - Jones, K AU - Burns, A J2 - Unit Costs of Health and Social Care PY - 2021 ER - TY - JOUR LB - 118. AU - Björk, J AU - Nyman, U AU - Courbebaisse, M AU - Couzi, L AU - Dalton, RN AU - Dubourg, L TI - Prospects for improved glomerular filtration rate estimation based on creatinine-results from a transnational multicentre study J2 - Clin Kidney J SP - 674 PY - 2020 VL - 13 SP - 674 ER - TY - JOUR LB - 119. AU - Preiss, DJ AU - Godber, IM AU - Lamb, EJ AU - Dalton, RN AU - Gunn, IR TI - The influence of a cooked-meat meal on estimated glomerular filtration rate J2 - Ann Clin Biochem SP - 35 PY - 2007 VL - 44 SP - 35 ER - TY - JOUR LB - 120. AU - Porrini, E AU - Ruggenenti, P AU - Luis-Lima, S AU - Carrara, F AU - Jiménez, A AU - de Vries, APJ TI - Estimated GFR: time for a critical appraisal J2 - Nat Rev Nephrol SP - 177 PY - 2019 VL - 15 SP - 177 ER - TY - JOUR LB - 121. AU - Shemesh, O AU - Golbetz, H AU - Kriss, JP AU - Myers, BD TI - Limitations of creatinine as a filtration marker in glomerulopathic patients J2 - Kidney Int SP - 830 PY - 1985 VL - 28 SP - 830 ER - TY - JOUR LB - 122. AU - Shah, KF AU - Stevens, PE AU - Lamb, EJ TI - The influence of a cooked-fish meal on estimated glomerular filtration rate J2 - Ann Clin Biochem SP - 182 PY - 2020 VL - 57 SP - 182 ER - TY - JOUR LB - 123. AU - Sveinbjornsson, G AU - Mikaelsdottir, E AU - Palsson, R AU - Indridason, OS AU - Holm, H AU - Jonasdottir, A TI - Rare mutations associating with serum creatinine and chronic kidney disease J2 - Hum Mol Genet SP - 6935 PY - 2014 VL - 23 SP - 6935 ER - TY - JOUR LB - 124. AU - Macdonald, J AU - Marcora, S AU - Jibani, M AU - Roberts, G AU - Kumwenda, M AU - Glover, R TI - GFR estimation using cystatin C is not independent of body composition J2 - Am J Kidney Dis SP - 712 PY - 2006 VL - 48 SP - 712 ER - TY - JOUR LB - 125. AU - Wasen, E AU - Isoaho, R AU - Mattila, K AU - Vahlberg, T AU - Kivelä, SL AU - Irjala, K TI - Serum cystatin C in the aged: relationships with health status J2 - Am J Kidney Dis SP - 36 PY - 2003 VL - 42 SP - 36 ER - TY - JOUR LB - 126. AU - Knight, EL AU - Verhave, JC AU - Spiegelman, D AU - Hillege, HL AU - de Zeeuw, D AU - Curhan, GC AU - de Jong, PE TI - Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement J2 - Kidney Int SP - 1416 PY - 2004 VL - 65 SP - 1416 ER - TY - JOUR LB - 127. AU - Liu, X AU - Foster, MC AU - Tighiouart, H AU - Anderson, AH AU - Beck, GJ AU - Contreras, G AU - CRIC (Chronic Renal Insufficiency Cohort) Study Investigators TI - Non-GFR determinants of low-molecular-weight serum protein filtration markers in CKD J2 - Am J Kidney Dis SP - 892 PY - 2016 VL - 68 SP - 892 ER - TY - JOUR LB - 128. AU - O’Seaghdha, CM AU - Tin, A AU - Yang, Q AU - Katz, R AU - Liu, Y AU - Harris, T TI - Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality J2 - Am J Kidney Dis SP - 16 PY - 2014 VL - 63 SP - 16 ER - TY - JOUR LB - 129. AU - Inker, LA AU - Tighiouart, H AU - Coresh, J AU - Foster, MC AU - Anderson, AH AU - Beck, GJ TI - GFR estimation using β-trace protein and β2-microglobulin in CKD J2 - Am J Kidney Dis SP - 40 PY - 2016 VL - 67 SP - 40 ER - TY - JOUR LB - 130. AU - Freed, TA AU - Coresh, J AU - Inker, LA AU - Toal, DR AU - Perichon, R AU - Chen, J TI - Validation of a metabolite panel for a more accurate estimation of glomerular filtration rate using quantitative LC-MS/MS J2 - Clin Chem SP - 406 PY - 2019 VL - 65 SP - 406 ER - TY - JOUR LB - 131. AU - Eckfeldt, JH AU - Karger, AB AU - Miller, WG AU - Rynders, GP AU - Inker, LA TI - Performance in measurement of serum cystatin C by laboratories participating in the College of American Pathologists 2014 CYS survey J2 - Arch Pathol Lab Med SP - 888 PY - 2015 VL - 139 SP - 888 ER - TY - JOUR LB - 132. AU - Karger, AB AU - Long, T AU - Inker, LA AU - Eckfeldt, JH AU - College of American Pathologists Accuracy Based Committee and Chemistry Resource Committee TI - Improved performance in measurement of serum cystatin C by laboratories participating in the College of American Pathologists’ 2019 CYS survey J2 - Arch Pathol Lab Med SP - 1218 PY - 2022 VL - 146 SP - 1218 ER - TY - JOUR LB - 133. AU - Shardlow, A AU - McIntyre, NJ AU - Fraser, SDS AU - Roderick, P AU - Raftery, J AU - Fluck, RJ TI - The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: a primary care cohort study J2 - PLOS Med SP - e1002400 PY - 2017 VL - 14 SP - e1002400 ER - TY - JOUR LB - 134. AU - Lamb, EJ AU - Tomson, CR AU - Roderick, PJ AU - Clinical Sciences Reviews Committee of the Association for Clinical Biochemistry TI - Estimating kidney function in adults using formulae J2 - Ann Clin Biochem SP - 321 PY - 2005 VL - 42 SP - 321 ER - TY - JOUR LB - 135. AU - Rule, AD AU - Larson, TS AU - Bergstralh, EJ AU - Slezak, JM AU - Jacobsen, SJ AU - Cosio, FG TI - Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease J2 - Ann Intern Med SP - 929 PY - 2004 VL - 141 SP - 929 ER - TY - JOUR LB - 136. AU - Faisal, W AU - Tang, HM AU - Tiley, S AU - Kukard, C TI - Not all body surface area formulas are the same, but does it matter? J2 - J Glob Oncol SP - 436 PY - 2016 VL - 2 SP - 436 ER - TY - JOUR LB - 137. AU - Blake, GM AU - Grewal, GS TI - An evaluation of the body surface area correction for 51Cr-EDTA measurements of glomerular filtration rate J2 - Nucl Med Commun SP - 447 PY - 2005 VL - 26 SP - 447 ER - TY - JOUR LB - 138. AU - Froissart, M AU - Rossert, J AU - Jacquot, C AU - Paillard, M AU - Houillier, P TI - Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function J2 - J Am Soc Nephrol SP - 763 PY - 2005 VL - 16 SP - 763 ER - TY - JOUR LB - 139. AU - Nyman, U AU - Grubb, A AU - Sterner, G AU - Björk, J TI - The CKD-EPI and MDRD equations to estimate GFR. Validation in the Swedish Lund-Malmö Study cohort J2 - Scand J Clin Lab Invest SP - 129 PY - 2011 VL - 71 SP - 129 ER - TY - JOUR LB - 140. AU - Poggio, ED AU - Wang, X AU - Greene, T AU - Van Lente, F AU - Hall, PM TI - Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease J2 - J Am Soc Nephrol SP - 459 PY - 2005 VL - 16 SP - 459 ER - TY - JOUR LB - 141. AU - Stevens, LA AU - Schmid, CH AU - Greene, T AU - Zhang, YL AU - Beck, GJ AU - Froissart, M TI - Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/173 m2 J2 - Am J Kidney Dis SP - 486 PY - 2010 VL - 56 SP - 486 ER - TY - JOUR LB - 142. AU - Gama, RM AU - Clery, A AU - Griffiths, K AU - Heraghty, N AU - Peters, AM AU - Palmer, K TI - Estimated glomerular filtration rate equations in people of self-reported black ethnicity in the United Kingdom: inappropriate adjustment for ethnicity may lead to reduced access to care J2 - PLOS ONE SP - e0255869 PY - 2021 VL - 16 SP - e0255869 ER - TY - JOUR LB - 143. AU - Fukushima, T AU - Nakano, J AU - Ishii, S AU - Natsuzako, A AU - Hirase, T AU - Sakamoto, J AU - Okita, M TI - Characteristics of muscle function and the effect of cachexia in patients with haematological malignancy J2 - Eur J Cancer Care (Engl) SP - e12956 PY - 2019 VL - 28 SP - e12956 ER - TY - JOUR LB - 144. AU - Hsu, CY AU - Yang, W AU - Parikh, RV AU - Anderson, AH AU - Chen, TK AU - Cohen, DL AU - CRIC Study Investigators TI - Race, genetic ancestry, and estimating kidney function in CKD J2 - N Engl J Med SP - 1750 PY - 2021 VL - 385 SP - 1750 ER - TY - JOUR LB - 145. AU - Lewis, J AU - Greene, T AU - Appel, L AU - Contreras, G AU - Douglas, J AU - Lash, J AU - AASK Study Group TI - A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension J2 - J Am Soc Nephrol SP - 3175 PY - 2004 VL - 15 SP - 3175 ER - TY - JOUR LB - 146. AU - Fontseré, N AU - Salinas, I AU - Bonal, J AU - Bayés, B AU - Riba, J AU - Torres, F TI - Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients? J2 - Nephrol Dial Transplant SP - 2152 PY - 2006 VL - 21 SP - 2152 ER - TY - JOUR LB - 147. AU - Rossing, P AU - Rossing, K AU - Gaede, P AU - Pedersen, O AU - Parving, HH TI - Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy J2 - Diabetes Care SP - 1024 PY - 2006 VL - 29 SP - 1024 ER - TY - JOUR LB - 148. AU - Xie, D AU - Joffe, MM AU - Brunelli, SM AU - Beck, G AU - Chertow, GM AU - Fink, JC TI - A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease J2 - Clin J Am Soc Nephrol SP - 1332 PY - 2008 VL - 3 SP - 1332 ER - TY - JOUR LB - 149. AU - Perkins, BA AU - Nelson, RG AU - Ostrander, BE AU - Blouch, KL AU - Krolewski, AS AU - Myers, BD AU - Warram, JH TI - Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study J2 - J Am Soc Nephrol SP - 1404 PY - 2005 VL - 16 SP - 1404 ER - TY - JOUR LB - 150. AU - de Boer, IH AU - Sun, W AU - Cleary, PA AU - Lachin, JM AU - Molitch, ME AU - Zinman, B AU - Steffes, MW AU - Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group TI - Longitudinal changes in estimated and measured GFR in type 1 diabetes J2 - J Am Soc Nephrol SP - 810 PY - 2014 VL - 25 SP - 810 ER - TY - JOUR LB - 151. AU - Lucas, GM AU - Atta, MG AU - Zook, K AU - Vaidya, D AU - Tao, X AU - Maier, P AU - Schwartz, GJ TI - Cross-sectional and longitudinal performance of creatinine- and cystatin C-based estimating equations relative to exogenously measured glomerular filtration rate in HIV-positive and HIV-negative persons J2 - J Acquir Immune Defic Syndr SP - e58 PY - 2020 VL - 85 SP - e58 ER - TY - JOUR LB - 152. AU - Lindeman, RD AU - Tobin, J AU - Shock, NW TI - Longitudinal studies on the rate of decline in renal function with age J2 - J Am Geriatr Soc SP - 278 PY - 1985 VL - 33 SP - 278 ER - TY - JOUR LB - 153. AU - Post, A AU - Tsikas, D AU - Bakker, SJL TI - Creatine is a conditionally essential nutrient in chronic kidney disease: a hypothesis and narrative literature review J2 - Nutrients SP - 1044 PY - 2019 VL - 11 SP - 1044 ER - TY - JOUR LB - 154. AU - Turin, TC AU - James, M AU - Ravani, P AU - Tonelli, M AU - Manns, BJ AU - Quinn, R TI - Proteinuria and rate of change in kidney function in a community-based population J2 - J Am Soc Nephrol SP - 1661 PY - 2013 VL - 24 SP - 1661 ER - TY - JOUR LB - 155. AU - Hoefield, RA AU - Kalra, PA AU - Lane, B AU - O’Donoghue, DJ AU - Foley, RN AU - Middleton, RJ TI - Associations of baseline characteristics with evolution of eGFR in a referred chronic kidney disease cohort J2 - QJM SP - 915 PY - 2013 VL - 106 SP - 915 ER - TY - JOUR LB - 156. AU - Melsom, T AU - Nair, V AU - Schei, J AU - Mariani, L AU - Stefansson, VTN AU - Harder, JL TI - Correlation between baseline GFR and subsequent change in GFR in Norwegian adults without diabetes and in Pima Indians J2 - Am J Kidney Dis SP - 777 PY - 2019 VL - 73 SP - 777 ER - TY - JOUR LB - 157. AU - Moore, KH AU - Clemmer, JS TI - Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling J2 - Am J Physiol Renal Physiol SP - F548 PY - 2021 VL - 321 SP - F548 ER - TY - JOUR LB - 158. AU - Levey, AS AU - Greene, T AU - Schluchter, MD AU - Cleary, PA AU - Teschan, PE AU - Lorenz, RA TI - Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group J2 - J Am Soc Nephrol SP - 1159 PY - 1993 VL - 4 SP - 1159 ER - TY - JOUR LB - 159. AU - Bröchner-Mortensen, J AU - Rödbro, P TI - Selection of routine method for determination of glomerular filtration rate in adult patients J2 - Scand J Clin Lab Invest SP - 35 PY - 1976 VL - 36 SP - 35 ER - TY - JOUR LB - 160. AU - Wilkinson, J AU - Fleming, JS AU - Waller, DG TI - Effect of food and activity on the reproducibility of isotopic GFR estimation J2 - Nucl Med Commun SP - 697 PY - 1990 VL - 11 SP - 697 ER - TY - JOUR LB - 161. AU - Carobene, A AU - Marino, I AU - Coskun, A AU - Serteser, M AU - Unsal, I AU - Guerra, E AU - European Biological Variation Study of the EFLM Working Group on Biological Variation TI - The EuBIVAS Project: within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring J2 - Clin Chem SP - 1527 PY - 2017 VL - 63 SP - 1527 ER - TY - JOUR LB - 162. AU - Waikar, SS AU - Rebholz, CM AU - Zheng, Z AU - Hurwitz, S AU - Hsu, CY AU - Feldman, HI TI - Biological variability of estimated GFR and albuminuria in CKD J2 - Am J Kidney Dis SP - 538 PY - 2018 VL - 72 SP - 538 ER - TY - JOUR LB - 163. AU - Selvin, E AU - Juraschek, SP AU - Eckfeldt, J AU - Levey, AS AU - Inker, LA AU - Coresh, J TI - Within-person variability in kidney measures J2 - Am J Kidney Dis SP - 716 PY - 2013 VL - 61 SP - 716 ER - TY - JOUR LB - 164. AU - Carter, JL AU - Parker, CT AU - Stevens, PE AU - Eaglestone, G AU - Knight, S AU - Farmer, CK AU - Lamb, EJ TI - Biological variation of plasma and urinary markers of acute kidney injury in patients with chronic kidney disease J2 - Clin Chem SP - 876 PY - 2016 VL - 62 SP - 876 ER - TY - JOUR LB - 165. AU - Podracka, L AU - Feber, J AU - Lepage, N AU - Filler, G TI - Intra-individual variation of cystatin C and creatinine in pediatric solid organ transplant recipients J2 - Pediatr Transplant SP - 28 PY - 2005 VL - 9 SP - 28 ER - TY - JOUR LB - 166. AU - Tan, GD AU - Lewis, AV AU - James, TJ AU - Altmann, P AU - Taylor, RP AU - Levy, JC TI - Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance J2 - Diabetes Care SP - 2004 PY - 2002 VL - 25 SP - 2004 ER - TY - JOUR LB - 167. AU - Hoek, FJ AU - Kemperman, FA AU - Krediet, RT TI - A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate J2 - Nephrol Dial Transplant SP - 2024 PY - 2003 VL - 18 SP - 2024 ER - TY - JOUR LB - 168. AU - Røraas, T AU - Petersen, PH AU - Sandberg, S TI - Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals J2 - Clin Chem SP - 1306 PY - 2012 VL - 58 SP - 1306 ER - TY - JOUR LB - 169. AU - Soveri, I AU - Berg, UB AU - Björk, J AU - Elinder, CG AU - Grubb, A AU - Mejare, I AU - SBU GFR Review Group TI - Measuring GFR: a systematic review J2 - Am J Kidney Dis SP - 411 PY - 2014 VL - 64 SP - 411 ER - TY - JOUR LB - 170. AU - Tangri, N AU - Stevens, LA AU - Griffith, J AU - Tighiouart, H AU - Djurdjev, O AU - Naimark, D TI - A predictive model for progression of chronic kidney disease to kidney failure J2 - JAMA SP - 1553 PY - 2011 VL - 305 SP - 1553 ER - TY - JOUR LB - 171. AU - Hasegawa, T AU - Sakamaki, K AU - Koiwa, F AU - Akizawa, T AU - Hishida, A AU - CKD-JAC Study Investigators TI - Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study J2 - Clin Exp Nephrol SP - 189 PY - 2019 VL - 23 SP - 189 ER - TY - JOUR LB - 172. AU - Go, AS AU - Chertow, GM AU - Fan, D AU - McCulloch, CE AU - Hsu, CY TI - Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization J2 - N Engl J Med SP - 1296 PY - 2004 VL - 351 SP - 1296 ER - TY - JOUR LB - 173. AU - Astor, BC AU - Hallan, SI AU - Miller, ER AU - Yeung, E AU - Coresh, J TI - Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population J2 - Am J Epidemiol SP - 1226 PY - 2008 VL - 167 SP - 1226 ER - TY - JOUR LB - 174. AU - Nitsch, D AU - Grams, M AU - Sang, Y AU - Black, C AU - Cirillo, M AU - Djurdjev, O AU - Chronic Kidney Disease Prognosis Consortium TI - Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis J2 - BMJ SP - f324 PY - 2013 VL - 346 SP - f324 ER - TY - JOUR LB - 175. AU - Swartling, O AU - Rydell, H AU - Stendahl, M AU - Segelmark, M AU - Trolle Lagerros, Y AU - Evans, M TI - CKD progression and mortality among men and women: a nationwide study in Sweden J2 - Am J Kidney Dis SP - 190 PY - 2021 VL - 78 SP - 190 ER - TY - JOUR LB - 176. AU - Matsushita, K AU - Mahmoodi, BK AU - Woodward, M AU - Emberson, JR AU - Jafar, TH AU - Jee, SH AU - Chronic Kidney Disease Prognosis Consortium TI - Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate J2 - JAMA SP - 1941 PY - 2012 VL - 307 SP - 1941 ER - TY - JOUR LB - 177. AU - Astor, BC AU - Shafi, T AU - Hoogeveen, RC AU - Matsushita, K AU - Ballantyne, CM AU - Inker, LA AU - Coresh, J TI - Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population J2 - Am J Kidney Dis SP - 653 PY - 2012 VL - 59 SP - 653 ER - TY - JOUR LB - 178. AU - Shlipak, MG AU - Matsushita, K AU - Ärnlöv, J AU - Inker, LA AU - Katz, R AU - Polkinghorne, KR AU - CKD Prognosis Consortium TI - Cystatin C versus creatinine in determining risk based on kidney function J2 - N Engl J Med SP - 932 PY - 2013 VL - 369 SP - 932 ER - TY - JOUR LB - 179. AU - Fleming, JS AU - Nunan, TO AU - British Nuclear Medicine Society TI - The new BNMS guidelines for measurement of glomerular filtration rate J2 - Nucl Med Commun SP - 755 PY - 2004 VL - 25 SP - 755 ER - TY - JOUR LB - 180. AU - Ebert, N AU - Loesment, A AU - Martus, P AU - Jakob, O AU - Gaedeke, J AU - Kuhlmann, M TI - Iohexol plasma clearance measurement in older adults with chronic kidney disease-sampling time matters J2 - Nephrol Dial Transplant SP - 1307 PY - 2015 VL - 30 SP - 1307 ER - TY - JOUR LB - 181. AU - Seegmiller, JC AU - Burns, BE AU - Schinstock, CA AU - Lieske, JC AU - Larson, TS TI - Discordance between iothalamate and iohexol urinary clearances J2 - Am J Kidney Dis SP - 49 PY - 2016 VL - 67 SP - 49 ER - TY - JOUR LB - 182. AU - Levey, AS AU - Inker, LA TI - GFR as the ‘gold standard’: estimated, measured, and true J2 - Am J Kidney Dis SP - 9 PY - 2016 VL - 67 SP - 9 ER - TY - BOOK LB - 183. AU - National Committee for Clinical Laboratory Standards J2 - Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline – Second Edition. NCCLS document EP9-A2 [ISBN 1-56238-472-4] PY - 2002 ER - TY - JOUR LB - 184. AU - Li, L AU - Astor, BC AU - Lewis, J AU - Hu, B AU - Appel, LJ AU - Lipkowitz, MS TI - Longitudinal progression trajectory of GFR among patients with CKD J2 - Am J Kidney Dis SP - 504 PY - 2012 VL - 59 SP - 504 ER - TY - JOUR LB - 185. AU - Ali, I AU - Chinnadurai, R AU - Ibrahim, ST AU - Kalra, PA TI - Adverse outcomes associated with rapid linear and non-linear patterns of chronic kidney disease progression J2 - BMC Nephrol SP - 82 PY - 2021 VL - 22 SP - 82 ER - TY - JOUR LB - 186. AU - Ali, I AU - Ibrahim, ST AU - Chinnadurai, R AU - Green, D AU - Taal, M AU - Whetton, TD AU - Kalra, PA TI - A paradigm to discover biomarkers associated with chronic kidney disease progression J2 - Biomark Insights SP - 1177271920976146 PY - 2020 VL - 15 SP - 1177271920976146 ER - TY - JOUR LB - 187. AU - Redwood, S AU - Gill, PS TI - Under-representation of minority ethnic groups in research – call for action J2 - Br J Gen Pract SP - 342 PY - 2013 VL - 63 SP - 342 ER - TY - JOUR LB - 188. AU - Smart, A AU - Harrison, E TI - The under-representation of minority ethnic groups in UK medical research J2 - Ethn Health SP - 65 PY - 2017 VL - 22 SP - 65 ER - TY - JOUR LB - 189. AU - Farooqi, A AU - Jutlla, K AU - Raghavan, R AU - Wilson, A AU - Uddin, MS AU - Akroyd, C TI - Developing a toolkit for increasing the participation of black, Asian and minority ethnic communities in health and social care research J2 - BMC Med Res Methodol SP - 17 PY - 2022 VL - 22 SP - 17 ER - TY - JOUR LB - 190. AU - Bodicoat, DH AU - Routen, AC AU - Willis, A AU - Ekezie, W AU - Gillies, C AU - Lawson, C TI - Promoting inclusion in clinical trials – a rapid review of the literature and recommendations for action J2 - Trials SP - 880 PY - 2021 VL - 22 SP - 880 ER - TY - JOUR LB - 191. AU - Ekezie, W AU - Czyznikowska, BM AU - Rohit, S AU - Harrison, J AU - Miah, N AU - Campbell-Morris, P AU - Khunti, K TI - The views of ethnic minority and vulnerable communities towards participation in COVID-19 vaccine trials J2 - J Public Health (Oxf) SP - e258 PY - 2021 VL - 43 SP - e258 ER - TY - JOUR LB - 192. AU - Major, RW AU - Shepherd, D AU - Medcalf, JF AU - Xu, G AU - Gray, LJ AU - Brunskill, NJ TI - The kidney failure risk equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study J2 - PLOS Med SP - e1002955 PY - 2019 VL - 16 SP - e1002955 ER - TY - JOUR LB - 193. AU - Drummond, MF AU - Jefferson, TO TI - Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party J2 - BMJ SP - 275 PY - 1996 VL - 313 SP - 275 ER - TY - JOUR LB - 194. AU - Gonzalez-Perez, JG TI - Developing a scoring system to quality assess economic evaluations J2 - Eur J Health Econ SP - 131 PY - 2002 VL - 3 SP - 131 ER - TY - JOUR LB - 195. AU - Siegel, JE AU - Krolewski, AS AU - Warram, JH AU - Weinstein, MC TI - Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus J2 - J Am Soc Nephrol SP - S111 PY - 1992 VL - 3 SP - S111 ER - TY - JOUR LB - 196. AU - Boulware, LE AU - Jaar, BG AU - Tarver-Carr, ME AU - Brancati, FL AU - Powe, NR TI - Screening for proteinuria in US adults: a cost-effectiveness analysis J2 - JAMA SP - 3101 PY - 2003 VL - 290 SP - 3101 ER - TY - JOUR LB - 197. AU - Palmer, AJ AU - Valentine, WJ AU - Chen, R AU - Mehin, N AU - Gabriel, S AU - Bregman, B AU - Rodby, RA TI - A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA J2 - Nephrol Dial Transplant SP - 1216 PY - 2008 VL - 23 SP - 1216 ER - TY - JOUR LB - 198. AU - Howard, K AU - White, S AU - Salkeld, G AU - McDonald, S AU - Craig, JC AU - Chadban, S AU - Cass, A TI - Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis J2 - Value Health SP - 196 PY - 2010 VL - 13 SP - 196 ER - TY - JOUR LB - 199. AU - Sekhar, DL AU - Wang, L AU - Hollenbeak, CS AU - Widome, MD AU - Paul, IM TI - A cost-effectiveness analysis of screening urine dipsticks in well-child care J2 - Pediatrics SP - 660 PY - 2010 VL - 125 SP - 660 ER - TY - JOUR LB - 200. AU - Kondo, M AU - Yamagata, K AU - Hoshi, SL AU - Saito, C AU - Asahi, K AU - Moriyama, T TI - Cost-effectiveness of chronic kidney disease mass screening test in Japan J2 - Clin Exp Nephrol SP - 279 PY - 2012 VL - 16 SP - 279 ER - TY - JOUR LB - 201. AU - Srisubat, A AU - Sriratanaban, J AU - Ngamkiatphaisan, S AU - Tungsanga, K TI - Cost-effectiveness of annual microalbuminuria screening in Thai diabetics J2 - Asian Biomed SP - 371 PY - 2014 VL - 8 SP - 371 ER - TY - JOUR LB - 202. AU - Go, DS AU - Kim, SH AU - Park, J AU - Ryu, DR AU - Lee, HJ AU - Jo, MW TI - Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea J2 - Nephrology (Carlton) SP - 56 PY - 2019 VL - 24 SP - 56 ER - TY - JOUR LB - 203. AU - Golan, L AU - Birkmeyer, JD AU - Welch, HG TI - The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors J2 - Ann Intern Med SP - 660 PY - 1999 VL - 131 SP - 660 ER - TY - JOUR LB - 204. AU - Kiberd, BA AU - Jindal, KK TI - Should all Pima Indians with type 2 diabetes mellitus be prescribed routine angiotensin-converting enzyme inhibition therapy to prevent renal failure? J2 - Mayo Clin Proc SP - 559 PY - 1999 VL - 74 SP - 559 ER - TY - JOUR LB - 205. AU - Boersma, C AU - Gansevoort, RT AU - Pechlivanoglou, P AU - Visser, ST AU - van Toly, FF AU - de Jong-van den Berg, LTW AU - Prevention of Renal and Vascular End Stage Disease Study Group TI - Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands J2 - Clin Ther SP - 1103 PY - 2010 VL - 32 SP - 1103 ER - TY - JOUR LB - 206. AU - Hoerger, TJ AU - Wittenborn, JS AU - Segel, JE AU - Burrows, NR AU - Imai, K AU - Eggers, P AU - Centers for Disease Control and Prevention CKD Initiative TI - A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences J2 - Am J Kidney Dis SP - 452 PY - 2010 VL - 55 SP - 452 ER - TY - JOUR LB - 207. AU - Hoerger, TJ AU - Wittenborn, JS AU - Segel, JE AU - Burrows, NR AU - Imai, K AU - Eggers, P AU - Centers for Disease Control and Prevention CKD Initiative TI - A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening J2 - Am J Kidney Dis SP - 463 PY - 2010 VL - 55 SP - 463 ER - TY - JOUR LB - 208. AU - Hoerger, TJ AU - Wittenborn, JS AU - Zhuo, X AU - Pavkov, ME AU - Burrows, NR AU - Eggers, P TI - Cost-effectiveness of screening for microalbuminuria among African Americans J2 - J Am Soc Nephrol SP - 2035 PY - 2012 VL - 23 SP - 2035 ER - TY - JOUR LB - 209. AU - Kessler, R AU - Keusch, G AU - Szucs, TD AU - Wittenborn, JS AU - Hoerger, TJ AU - Brügger, U AU - Wieser, S TI - Health economic modelling of the cost-effectiveness of microalbuminuria screening in Switzerland J2 - Swiss Med Wkly SP - w13508 PY - 2012 VL - 142 SP - w13508 ER - TY - JOUR LB - 210. AU - Farmer, AJ AU - Stevens, R AU - Hirst, J AU - Lung, T AU - Oke, J AU - Clarke, P TI - Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment – systematic review and modelling of progression and cost-effectiveness J2 - Health Technol Assess SP - 1 PY - 2014 VL - 18 SP - 1 ER - TY - JOUR LB - 211. AU - Ferguson, TW AU - Tangri, N AU - Tan, Z AU - James, MT AU - Lavallee, BDA AU - Chartrand, CD TI - Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective J2 - Kidney Int SP - 192 PY - 2017 VL - 92 SP - 192 ER - TY - JOUR LB - 212. AU - Wang, H AU - Yang, L AU - Wang, F AU - Zhang, L TI - Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease J2 - BMC Nephrol SP - 135 PY - 2017 VL - 18 SP - 135 ER - TY - JOUR LB - 213. AU - Yarnoff, BO AU - Hoerger, TJ AU - Simpson, SK AU - Leib, A AU - Burrows, NR AU - Shrestha, SS AU - Pavkov, ME AU - Centers for Disease Control and Prevention CKD Initiative TI - The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease J2 - BMC Nephrol SP - 85 PY - 2017 VL - 18 SP - 85 ER - TY - JOUR LB - 214. AU - Wu, B AU - Zhang, S AU - Lin, H AU - Mou, S TI - Prevention of renal failure in Chinese patients with newly diagnosed type 2 diabetes: a cost-effectiveness analysis J2 - J Diabetes Investig SP - 152 PY - 2018 VL - 9 SP - 152 ER - TY - JOUR LB - 215. AU - Le Floch, JP AU - Charles, MA AU - Philippon, C AU - Perlemuter, L TI - Cost-effectiveness of screening for microalbuminuria using immunochemical dipstick tests or laboratory assays in diabetic patients J2 - Diabet Med SP - 349 PY - 1994 VL - 11 SP - 349 ER - TY - JOUR LB - 216. AU - Kiberd, BA AU - Jindal, KK TI - Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation J2 - BMJ SP - 1595 PY - 1995 VL - 311 SP - 1595 ER - TY - JOUR LB - 217. AU - Kiberd, BA AU - Jindal, KK TI - Routine treatment of insulin-dependent diabetic patients with ACE inhibitors to prevent renal failure: an economic evaluation J2 - Am J Kidney Dis SP - 49 PY - 1998 VL - 31 SP - 49 ER - TY - JOUR LB - 218. AU - Adarkwah, CC AU - Gandjour, A TI - Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany J2 - Int J Technol Assess Health Care SP - 62 PY - 2010 VL - 26 SP - 62 ER - TY - JOUR LB - 219. AU - Adarkwah, CC AU - Gandjour, A AU - Akkerman, M AU - Evers, SM TI - Cost-effectiveness of angiotensin-converting enzyme inhibitors for the prevention of diabetic nephropathy in The Netherlands – a Markov model J2 - PLOS ONE SP - e26139 PY - 2011 VL - 6 SP - e26139 ER - TY - JOUR LB - 220. AU - den Hartog, JR AU - Reese, PP AU - Cizman, B AU - Feldman, HI TI - The costs and benefits of automatic estimated glomerular filtration rate reporting J2 - Clin J Am Soc Nephrol SP - 419 PY - 2009 VL - 4 SP - 419 ER - TY - JOUR LB - 221. AU - Manns, B AU - Hemmelgarn, B AU - Tonelli, M AU - Au, F AU - Chiasson, TC AU - Dong, J AU - Klarenbach, S AU - Alberta Kidney Disease Network TI - Population based screening for chronic kidney disease: cost effectiveness study J2 - BMJ SP - c5869 PY - 2010 VL - 341 SP - c5869 ER - TY - JOUR LB - 222. AU - Ravaghi, H AU - Ebrahimnia, M AU - Farzanah, A AU - Rostami, Z AU - Madani, M TI - Cost-effectiveness analysis of screening chronic kidney disease in Iran J2 - J Clin Diagn Res SP - IC01 PY - 2019 VL - 13 SP - IC01 ER - TY - JOUR LB - 223. AU - Critselis, E AU - Vlahou, A AU - Stel, VS AU - Morton, RL TI - Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion J2 - Nephrol Dial Transplant SP - 441 PY - 2018 VL - 33 SP - 441 ER -